The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis
Open accessAbstract
OBJECTIVE: Accumulating evidence links the intestinal microbiota and colorectal carcinogenesis. Fusobacterium nucleatum may promote colorectal tumour growth and inhibit T cell-mediated immune responses against colorectal tumours. Thus, we hypothesised that the amount of F. nucleatum in colorectal carcinoma might be associated with worse clinical outcome. DESIGN: We used molecular pathological epidemiology database of 1069 rectal and colon cancer cases in the Nurses' Health Study and the Health Professionals Follow-up Study, and measured F. nucleatum DNA in carcinoma tissue. Cox proportional hazards model was used to compute hazard ratio (HR), controlling for potential confounders, including microsatellite instability (MSI, mismatch repair deficiency), CpG island methylator phenotype (CIMP), KRAS, BRAF, and PIK3CA mutations, and LINE-1 hypomethylation (low-level methylation). RESULTS: Compared with F. nucleatum-negative cases, multivariable HRs (95% CI) for colorectal cancer-specific mortality in F. nucleatum-low cases and F. nucleatum-high cases were 1.25 (0.82 to 1.92) and 1.58 (1.04 to 2.39), respectively, (p for trend=0.020). The amount of F. nucleatum was associated with MSI-high (multivariable odd ratio (OR), 5.22; 95% CI 2.86 to 9.55) independent of CIMP and BRAF mutation status, whereas CIMP and BRAF mutation were associated with F. nucleatum only in univariate analyses (p<0.001) but not in multivariate analysis that adjusted for MSI status. CONCLUSIONS: The amount of F. nucleatum DNA in colorectal cancer tissue is associated with shorter survival, and may potentially serve as a prognostic biomarker. Our data may have implications in developing cancer prevention and treatment strategies through targeting GI microflora by diet, probiotics and antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies, of multiple cohorts, of patients with CRC worldwide have found similar associations.23–27”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,925
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718
Self-citationRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma
Castellarin, M., Warren, R. L., Freeman, J. D., Dreolini, L., Krzywinski, M., Strauss, J., Barnes, R., Watson, P., Allen-Vercoe, E., Moore, R. A., et al. (2012) · Genome Research · doi:10.1101/gr.126516.111 · Cited by 2,043
Genomic analysis identifies association of Fusobacterium with colorectal carcinoma
Kostic, A. D., Gevers, D., Pedamallu, C. S., Michaud, M., Duke, F., Earl, A. M., Ojesina, A. I., Jung, J., Bass, A. J., Tabernero, J., et al. (2012) · Genome Research · doi:10.1101/gr.126573.111 · Cited by 1,960
Self-citationGur, C., Ibrahim, Y., Isaacson, B., Yamin, R., Abed, J., Gamliel, M., Enk, J., Bar-On, Y., Stanietsky-Kaynan, N., Coppenhagen-Glazer, S., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.01.010 · Cited by 1,490
Self-citationLong-term colorectal-cancer incidence and mortality after lower endoscopy
Nishihara, R., Wu, K., Lochhead, P., Morikawa, T., Liao, X., Qian, Z. R., Inamura, K., Kim, S. A., Kuchiba, A., Yamauchi, M., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301969 · Cited by 1,483
Self-citationGarrett, W. S. (2015) · Science · doi:10.1126/science.aaa4972 · Cited by 1,404
Self-citationSystemic Therapy for Colorectal Cancer
Meyerhardt, J. A., & Mayer, R. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra040958 · Cited by 1,080
Self-citationSystemic Therapy for Colorectal Cancer
Varghese, A. M. (2019) · DeckerMed CGSO Case-Based Reviews · doi:10.2310/cgso.16189 · Cited by 883
Cited by
Sorted by citations
Items 601–700 of 1,000
Acar, C., Küçükyıldırım, S., Özdemirel, H. Ö., Erdem, B., Alan, S., & Mergen, H. (2023) · Folia Microbiologica · doi:10.1007/s12223-023-01072-w · Cited by 13
Đerfi, K. V., Salar, A., Čaćev, T., & Kapitanović, S. (2023) · Genes · doi:10.3390/genes14071474 · Cited by 13
Fusobacterium species are distinctly associated with patients with Lynch syndrome colorectal cancer
Salim, F., Mizutani, S., Shiba, S., Takamaru, H., Yamada, M., Nakajima, T., Yachida, T., Soga, T., Saitō, Y., Fukuda, S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110181 · Cited by 14
Guideline for designing microbiome studies in neoplastic diseases
Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., & Bai, P. (2024) · GeroScience · doi:10.1007/s11357-024-01255-4 · Cited by 13
Selvaraj, A., McManus, G., Healy, C. M., & Moran, G. P. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1417946 · Cited by 13
Byrd, D. A., Damerell, V., Gómez, M. F. L., Hogue, S., Lin, T., Ose, J., Himbert, C., Ilozumba, M. N., Kahlert, C., Shibata, D., et al. (2025) · International Journal of Cancer · doi:10.1002/ijc.35342 · Cited by 13
Alberti, G., Mazzola, M., Gagliardo, C. M., Pitruzzella, A., Fucarini, A., Giammanco, M., Tomasello, G., & Carini, F. (2021) · Biomedical Papers · doi:10.5507/bp.2021.042 · Cited by 13
Influence of the Microbiome Metagenomics and Epigenomics on Gastric Cancer
Mathebela, P., Damane, B. P., Mulaudzi, T. V., Mkhize‐Kwitshana, Z. L., Gaudji, G. R., & Dlamini, Z. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213750 · Cited by 14
Chen, Y., Liao, X., Li, Y., Cao, H., Zhang, F., Fei, B., Bao, C., Cao, H., Mao, Y., Chen, X., et al. (2023) · Trials · doi:10.1186/s13063-023-07137-y · Cited by 14
Detection of Fusobacterium nucleatum in Patients with Colitis-Associated Colorectal Cancer
Dregelies, T., Haumaier, F., Sterlacci, W., Backert, S., & Vieth, M. W. (2023) · Current Microbiology · doi:10.1007/s00284-023-03398-7 · Cited by 13
Huang, C., Liu, H., Gong, X., Wu, L., & Wen, B. (2016) · Oncology Reports · doi:10.3892/or.2016.5104 · Cited by 13
He, X., Zhao, Q., Zhang, J., Shi, J., Wan, N., Tang, B., Tian, B., & Li, P. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1652702 · Cited by 12
Caulobacter and Novosphingobium in tumor tissues are associated with colorectal cancer outcomes
Zhou, B., Shi, L., Jin, M., Cheng, M., Yu, D., Zhao, L., Zhang, J., Yu, C., Zhang, T., & Liu, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2022.1078296 · Cited by 12
Bacteria and macrophages in the tumor microenvironment
Xu, S. S., Xiong, Y., Fu, B., Guo, D. L., Sha, Z., Lin, X., & Wu, H. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1115556 · Cited by 13
Papadimitriou, N., Qu, C., Harrison, T. A., Bever, A. M., Martin, R. M., Tsilidis, K. K., Newcomb, P. A., Thibodeau, S. N., Newton, C. C., Um, C. Y., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105010 · Cited by 13
Self-citationLehr, K., Lange, U. G., Hipler, N. M., Vilchez‐Vargas, R., Hoffmeister, A., Feisthammel, J., Buchloh, D., Schanze, D., Zenker, M., Gockel, I., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-65320-w · Cited by 13
Cern, A., Skoczen, S. L., Snapp, K. S., Hod, A., Zilbersheid, D., Bavli, Y., Alon‐Maimon, T., Bachrach, G., Wei, X., Berman, B., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.07.045 · Cited by 13
The role of Fusobacterium nucleatum in the pathogenesis of colon cancer
Hong, B., Chhaya, A., Robles, A., Cervantes, J., & Tiwari, S. (2024) · Journal of Investigative Medicine · doi:10.1177/10815589241277829 · Cited by 15
Wang, P., Huang, Q.-Z., Zhu, Y., Chen, L., & Ye, K. (2024) · Advanced Biology · doi:10.1002/adbi.202400293 · Cited by 12
Wang, X., Zhang, D., Zhang, C., & Sun, Y. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.94 · Cited by 11
PM2RA: A Framework for Detecting and Quantifying Relationship Alterations in Microbial Community
Liu, Z., Mi, K., Xu, Z. Z., Zhang, Q., & Liu, X. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.07.005 · Cited by 12
Nicolae, F. M., Didilescu, A. C., Șurlin, P., Ungureanu, B. S., Şurlin, V., Pătrașcu, Ș., Râmboiu, S., Jelihovschi, I., Iancu, L. S., Ghiluşi, M. C., et al. (2022) · Pathogens · doi:10.3390/pathogens11030360 · Cited by 12
Fusobacterium nucleatum load in MSI colorectal cancer subtypes
Ono, T., Yamaguchi, T., Takao, M., Kojika, E., Iijima, T., & Horiguchi, S. (2022) · International Journal of Clinical Oncology · doi:10.1007/s10147-022-02218-5 · Cited by 13
Wang, Y., Wen, Y., Wang, J., Lai, X., Xu, Y., Zhang, X., Zhu, X., Ruan, C., & Huang, Y. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.945463 · Cited by 12
Profir, M., Roşu, O., Creţoiu, S. M., & Gașpar, B. S. (2024) · Microorganisms · doi:10.3390/microorganisms12050955 · Cited by 12
Global Epidemiology of Gastrointestinal Cancers
Dızdar, Ö., & Kılıçkap, S. (2019) · Springer eBooks · doi:10.1007/978-3-030-18890-0_1 · Cited by 14
The Function of the Oral Microbiome in Health and Disease
Frias‐Lopez, J., & Duran-Pinedo, A. E. (2020) · Springer eBooks · doi:10.1007/978-3-030-42990-4_10 · Cited by 12
Impacts of Habitual Diets Intake on Gut Microbial Counts in Healthy Japanese Adults
Sugimoto, T., Shima, T., Amamoto, R., Kaga, C., Kado, Y., Watanabe, O., Shiinoki, J., Iwazaki, K., Shigemura, H., Tsuji, H., et al. (2020) · Nutrients · doi:10.3390/nu12082414 · Cited by 12
Application of Fusobacterium nucleatum as a biomarker in gastrointestinal malignancies
Yu, L.-C., Li, Y.-P., Xin, Y.-M., Mao, M., Pan, Y.-X., Qu, Y.-X., Luo, Z.-D., Zhang, Y., & Zhang, X. (2024) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v16.i6.2271 · Cited by 13
Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential
Luo, M., Chen, X., Gao, H., Yang, F., Chen, J., & Qiao, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.980111 · Cited by 10
Baik, J. E., Li, L., Shah, M. A., Freedberg, D. E., Jin, Z., Wang, T. C., & Han, Y. W. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0248 · Cited by 11
Rat, L. A., Moldovan, A. F., Trifan, D., Matiș, L., Murvai, G. F., Mariș, L., Ghitea, T. C., & Maghiar, M. A. (2023) · Biomedicines · doi:10.3390/biomedicines11020402 · Cited by 12
Ugai, T., Shimizu, T., Kawamura, H., Ugai, S., Takashima, Y., Usui, G., Väyrynen, J. P., Okadome, K., Haruki, K., Akimoto, N., et al. (2023) · Clinical & Translational Immunology · doi:10.1002/cti2.1453 · Cited by 12
Self-citationIntratumoral microorganisms in tumors of the digestive system
Xuan, M., Gu, X., Liu, Y., Li, Y., Li, Y., Huang, D., Li, J., & Xue, C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01425-5 · Cited by 13
Gut microbiome as a treatment in colorectal cancer
Khan, M., Shah, S., Shah, W., Khan, I., Ali, H., Ali, I., Ullah, R., Wang, X., Mehmood, A., & Wang, Y. (2024) · International Reviews of Immunology · doi:10.1080/08830185.2024.2312294 · Cited by 12
Metastasis and the Microbiome: The Impact of Bacteria in Disseminated Colorectal Cancer
Ayabe, R. I., & White, M. G. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904152 · Cited by 12
Liu, Y., Lin, H., Zhong, W., Zeng, Y., Zhou, G., Chen, Z., Huang, S., Zhang, L., & Liu, X. (2024) · Clinical Oral Investigations · doi:10.1007/s00784-024-05645-y · Cited by 11
Wanitsuwan, W., Pahumunto, N., Surachat, K., Thananimit, S., Wonglapsuwan, M., Laohawiriyakamol, S., & Teanpaisan, R. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106576 · Cited by 11
Chang, Y., Long, M., Shan, H., Liu, L., Zhong, S., & Luo, J. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104629 · Cited by 12
Duan, C., Sheng, J.-Q., & Ma, X. (2025) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848251314829 · Cited by 12
Booth, M. E., Wood, H. M., Travis, M. A., Ambrose, J. C., Arumugam, P., Bevers, R. P. J., Bleda, M., Boardman-Pretty, F., Boustred, C. R., Brittain, H. K., et al. (2025) · Gastric Cancer · doi:10.1007/s10120-025-01588-9 · Cited by 11
Li, J., Hu, X., & Zhang, S. (2025) · Oncology Letters · doi:10.3892/ol.2025.15281 · Cited by 11
Risoen, K. R., Shaw, C. A., CHIEN, J. R., & Weimer, B. C. (2025) · Cancers · doi:10.3390/cancers17193247 · Cited by 11
Bairi, K. E., Jabi, R., Trapani, D., Boutallaka, H., Bencheikh, B. O. A., Bouziane, M., Amrani, M., Afqir, S., & Maleb, A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1758063 · Cited by 11
Kaczmarek, K., Wieckiewicz, J., Węglarczyk, K., Siedlar, M., & Baran, J. (2021) · Cancers · doi:10.3390/cancers13123004 · Cited by 11
Morsi, H., Golizeh, M., Brosseau, N. E., Janati, A. I., Emami, E., Ndao, M., & Tran, S. D. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105337 · Cited by 11
Li, X., Feng, J., Wang, Z., Liu, G., & Wang, F. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1236583 · Cited by 12
Takeda, K., Koi, M., Okita, Y., Sajibu, S., Keku, T. O., & Carethers, J. M. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-23-0179 · Cited by 11
Chen, Y., & Lai, X. (2022) · Mathematical Biosciences · doi:10.1016/j.mbs.2022.108868 · Cited by 12
Gastrointestinal cancer: molecular pathogenesis and targeted therapy
Jin, Y., He, X., & Wu, Y. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00361-9 · Cited by 13
Appiah, E. M., Yakubu, B., & Salifu, S. P. (2023) · The Microbe · doi:10.1016/j.microb.2023.100009 · Cited by 10
Diabetes Risk Reduction Diet and Colorectal Cancer Risk
Natale, A., Turati, F., Taborelli, M., Giacosa, A., Augustin, L. S. A., Crispo, A., Negri, E., Rossi, M., & Vecchia, C. L. (2024) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-23-1400 · Cited by 10
Zhao, S., Yu, Y., Xin, Y., Lu, H., Li, X., Wang, S., Ma, F., & Gao, H. (2025) · Nano Today · doi:10.1016/j.nantod.2025.102742 · Cited by 10
The Regional Specificity of Mucosa-Associated Microbiota in Patients with Distal Colorectal Cancer
Kono, Y., Inoüe, R., Teratani, T., Tojo, M., Kumagai, Y., Morishima, S., Koinuma, K., Lefor, A. K., Kitayama, J., Sata, N., et al. (2021) · Digestion · doi:10.1159/000519487 · Cited by 12
Yang, S., Hao, S., Ye, H., & Zhang, X. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1083987 · Cited by 10
Baliou, S., Adamaki, M., Spandidos, D. A., Kyriakopoulos, A. M., Christodoulou, I., & Zoumpourlis, V. C. (2018) · World Academy of Sciences Journal · doi:10.3892/wasj.2018.6 · Cited by 11
Panyathep, A., & Chewonarin, T. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13487 · Cited by 10
Mancheño, J. M., Atondo, E., Tomás‐Cortázar, J., Lavín, J. L., Plaza‐Vinuesa, L., Martín‐Ruiz, I., Barriales, D., Palacios, A., Navo, C. D., Sampedro, L., et al. (2020) · Microbial Biotechnology · doi:10.1111/1751-7915.13732 · Cited by 11
Li, J., Wei, Z., Cao, S., Tan, X., Liu, S., Yao, Z., Sun, T., Li, Y., Zhang, D., & Zhou, Y. (2019) · Cancer Epidemiology · doi:10.1016/j.canep.2019.02.001 · Cited by 10
Fusobacteria alterations are associated with colorectal cancer liver metastasis and a poor prognosis
Jin, M., Fan, Q., Shang, F., Zhang, T., Ogino, S., & Liu, H. (2024) · Oncology Letters · doi:10.3892/ol.2024.14368 · Cited by 9
Self-citationKawamura, H., Ugai, T., Takashima, Y., Okadome, K., Shimizu, T., Mima, K., Akimoto, N., Haruki, K., Arima, K., Zhao, M. M., et al. (2024) · Annals of Surgery · doi:10.1097/sla.0000000000006315 · Cited by 9
Self-citationThe interactions between gut microbiota and Chinese herbal medicine in colorectal cancer
Hou, X., Li, X., Chen, W., Zhu, W., Guo, H., & Zhao, L. (2025) · Acupuncture and Herbal Medicine · doi:10.1097/hm9.0000000000000153 · Cited by 10
Dan, W., Xiong, C., Zhou, G., Chen, J., & Pan, F. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189381 · Cited by 10
Krokosz, S., Obrycka, M., & Zalewska, A. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080647 · Cited by 9
Sorrenti, E., Governa, V., Bressan, D., Cremonesi, E., Formaggio, N., Latino, I., Calì, B., Torcasio, C., Basso, C., Galafassi, J., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.02.006 · Cited by 9
Microbe-driven immune suppression in colorectal cancer: the Fusobacterium nucleatum playbook
Wuyi, W., & Tao, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1795703 · Cited by 12
Biodiversity and biogeography of the multi-kingdom cancer microbiome
Dohlman, A. B., Mjelle, R., Wood, H. M., Jiang, K., Shumate, A., Lee, I., Piccinno, G., Serna, G., Yakubu, A.-R., Nuciforo, P. G., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.015 · Cited by 11
Self-citationRole of human microbiota in the development of colorectal cancer
Kochkina, S. O., Гордеев, С. С., & Mamedli, Z. Z. (2019) · Surgery and Oncology · doi:10.17650/2686-9594-2019-9-3-11-17 · Cited by 9
From Intestinal Epithelial Homeostasis to Colorectal Cancer: Autophagy Regulation in Cellular Stress
Liu, Q.-L., Chen, Y., Zhou, L., Chen, H., & Zhou, Z. (2022) · Antioxidants · doi:10.3390/antiox11071308 · Cited by 9
Use of Personalized Biomarkers in Metastatic Colorectal Cancer and the Impact of AI
Volovăț, S. R., Augustin, I. G., Zob, D., Boboc, D., Amurariti, F., Volovat, C. D., Ştefănescu, C., Stolniceanu, C. R., Ciocoiu, M., Dumitras, E. A., et al. (2022) · Cancers · doi:10.3390/cancers14194834 · Cited by 10
The role of Fusobacteria in oral cancer and immune evasion
Harrandah, A. M. (2023) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000927 · Cited by 9
The Influence of the Microbiome on Metastatic Colorectal Cancer
Cass, S. H., & White, M. G. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1760864 · Cited by 9
Yeo, K. K. L., Li, R., Wu, F., Bouras, G. S., H., L., Smith, E., Wormald, P., Valentine, R. J., Psaltis, A. J., Vreugde, S., et al. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001799 · Cited by 10
Science in Focus: The Microbiome and Cancer Therapy
Alexander, J. L., Kohoutová, D., & Powell, N. (2018) · Clinical Oncology · doi:10.1016/j.clon.2018.09.004 · Cited by 9
Park, S. S., Kim, B., Kim, M. J., Roh, S. J., Park, S. C., Kim, B. C., Han, K. S., Hong, C. W., Sohn, D. K., & Oh, J. H. (2020) · Annals of Surgical Treatment and Research · doi:10.4174/astr.2020.99.1.44 · Cited by 9
CEACAM1 Activation by CbpF-Expressing E. coli
Shhadeh, A., Galaski, J., Alon‐Maimon, T., Fahoum, J., Wiener, R., Slade, D. J., Mandelboim, O., & Bachrach, G. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.699015 · Cited by 9
Interdental Plaque Microbial Community Changes under In Vitro Violet LED Irradiation
Wang, D., Nambu, T., Tanimoto, H., Iwata, N., Yoshikawa, K., Okinaga, T., & Yamamoto, K. (2021) · Antibiotics · doi:10.3390/antibiotics10111348 · Cited by 9
Bacterial snack attack deactivates a drug
Jobin, C. (2017) · Nature · doi:10.1038/550337a · Cited by 9
Sociodemographic patterning in the oral microbiome of a diverse sample of New YorkersPreprint
Renson, A., Jones, H. E., Beghini, F., Segata, N., Zolnik, C. P., Usyk, M., Moody, T. U., Thorpe, L. E., Burk, R. D., Waldron, L., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/189225 · Cited by 9
Gut Microbiota and Cancer Patients: A Broad-Ranging Relationship
Cammarota, G., & Ianiro, G. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.09.009 · Cited by 9
Fang, L., Yao, Y., Guan, X., Liao, Y., Wang, B., Cui, L., Han, S., Zou, H., Su, D., Ma, Y., et al. (2023) · International Journal of Cancer · doi:10.1002/ijc.34539 · Cited by 9
Exploring the Interplay: Oral–Gut Microbiome Connection and the Impact of Diet and Nutrition
Parveen, S., Alqahtani, A. S., Aljabri, M. Y., Dawood, T., Khan, S. S., Gupta, B., Vempalli, S., Hassan, A. A.-H. A.-A., & Elamin, N. M. H. (2024) · European Journal of General Dentistry · doi:10.1055/s-0044-1786154 · Cited by 11
Association of Fusobacterium nucleatum infection with colorectal cancer in Kazakhstani patients
Kulmambetova, G., Kurentay, B., Гусмаулемова, А., Utupov, T., Auganova, D., Tarlykov, P., Mamlin, M., Khamzina, S., Shalekenov, S. B., & Kozhakhmetov, A. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1473575 · Cited by 8
Intratumor microbiota and colorectal cancer: Comprehensive and lucid review
Zong, Z., Zeng, W., Li, Y., Wang, M., Cao, Y., Cheng, X., Jin, Z., Mao, S., & Zhu, X. (2024) · Chinese Journal of Cancer Research · doi:10.21147/j.issn.1000-9604.2024.06.07 · Cited by 8
Self-citationYe, C., Zhang, B., Lin, Y., Han, F., Shi, H., Dong, C., & Zhou, W. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1523863 · Cited by 9
Wang, T., Lin, S., Ji, Y. B., Puqiong, C., Gao, J., & Li, S. (2025) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_38_24 · Cited by 8
Makkar, S. K., & Bishnupuri, K. S. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1676796 · Cited by 10
Ye, C., Shi, M., Ren, J., Zhang, Y., Zhang, Y., Zhang, Y., Du, Y., Wang, X., & Liu, Q. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1714335 · Cited by 8
Genetic heterogeneity of colorectal cancer and the microbiome
Senchukova, M. A. (2023) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v15.i3.443 · Cited by 9
Transformation of colitis and colorectal cancer: a tale of gut microbiota
Xia, K., Gao, R., Li, L., Wu, X., Wu, T., Ruan, Y., Yin, L., & Chen, C. (2023) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2023.2254388 · Cited by 9
Nakano, T., Dohi, O., Takagi, T., Naito, Y., Fukui, H., Miyazaki, H., Yasuda, T., Yoshida, T., Azuma, Y., Ishida, T., et al. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08154-2 · Cited by 8
Chen, Y., Zheng, Y., & Liu, S. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70182 · Cited by 8
Zepeda‐Rivera, M. A., Eisele, Y., Baryiames, A. A., Wu, H., Mengoni, C., Piccinno, G., McMahon, E. F., LaCourse, K. D., Jones, D. S., Hauner, H., et al. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2442522 · Cited by 9
Self-citationMarongiu, G. L., Fink, U., Schöpf, F., Oder, A., von Kries, J. P., & Roderer, D. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2418155122 · Cited by 9
Peng, M., Zheng, Q., Liu, P., Liang, X., Zhang, M., Wang, Y., & Zhao, Y. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29322 · Cited by 8
A Perspective: Integrating Dental and Medical Research Improves Overall Health
Mouradian, W. E., Lee, J. C., Wilentz, J., & Somerman, M. J. (2021) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2021.699575 · Cited by 9
Microbiome and Colorectal Cancer Management
Alrahawy, M., Javed, S., Atif, H., ElSanhoury, K., Mekhaeil, K., & Eskander, G. H. (2022) · Cureus · doi:10.7759/cureus.30720 · Cited by 8
The Influence of the Gut Microbiome in Paediatric Cancer Origin and Treatment
Sági, V., Makra, N., Csoszánszki, N., Decmann, Á., Szabó, D., & Garami, M. (2022) · Antibiotics · doi:10.3390/antibiotics11111521 · Cited by 9
Antibodies to oral pathobionts and colon cancer risk in the CLUE I cohort study
Debertin, J. G., Teles, F., Martin, L. M., Lu, J., Koestler, D. C., Kelsey, K. T., Beck, J. D., Platz, E. A., & Michaud, D. S. (2023) · International Journal of Cancer · doi:10.1002/ijc.34527 · Cited by 8
Palmieri, O., Castellana, S., Latiano, A., Latiano, T. P., Gentile, A., Panza, A., Nardella, M., Ciardiello, D., Latiano, T. P., Corritore, G., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11051147 · Cited by 9
Metadata
- Authors
- Mima, K., Nishihara, R., Qian, Z. R., Cao, Y., Sukawa, Y., Nowak, J. A., Yang, J., Dou, R., Masugi, Y., Song, M., Kostic, A. D., Giannakis, M., Bullman, S., Milner, D. A., Baba, H., Giovannucci, E. L., Garraway, L. A., Freeman, G. J., Dranoff, G., Garrett, W. S., Huttenhower, C., Meyerson, M., Meyerhardt, J. A., Chan, A. T., Fuchs, C. S., & Ogino, S.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Broad Institute (US)
- Kumamoto University (JP)
- Corresponding author
- Ogino, Shuji
- ORCID
- Mima, Kosuke
- Nishihara, Reiko
- Qian, Zhi Rong
- Cao, Yin
- Sukawa, Yasutaka
- Nowak, Jonathan A
- Yang, Juhong
- Dou, Ruoxu
- Masugi, Yohei
- Song, Mingyang
- Kostic, Aleksandar D
- Giannakis, Marios
- Bullman, Susan
- Milner, Danny A
- Baba, Hideo
- Giovannucci, Edward L
- Garraway, Levi A
- Freeman, Gordon J
- Dranoff, Glenn
- Garrett, Wendy S
- Huttenhower, Curtis
- Meyerson, Matthew
- Meyerhardt, Jeffrey A
- Chan, Andrew T
- Fuchs, Charles S
- Ogino, Shuji
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2015-08-26
- Volume
- 65
- Issue
- 12
- Pages
- 1973-1980
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- PMC
- PMC4769120
- OpenAlex
- W2199896469
- Cited by
- 1,080
- References
- 53
- Citations by year
- 2026: 108 · 2025: 116 · 2024: 131 · 2023: 119 · 2022: 141 · 2021: 140 · 2020: 105 · 2019: 71 · 2018: 64 · 2017: 47 · 2016: 34 · 2015: 4
- FWCI
- 21.44
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gut (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR001100)
- National Cancer Institute (P50CA127003, R01CA151993, R01CA118553, R01CA137178, R35CA197735, P01CA087969, R01CA169141, K07CA122826, P01CA055075, UM1CA186107, UM1CA167552, K07CA190673, R01CA154426)
- National Institute of Diabetes and Digestive and Kidney Diseases (K24DK098311)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Keywords
- Fusobacterium nucleatum, colorectal cancer, rectal cancer, colon cancer, prognosis, colorectal cancer-specific mortality, tumor microbiome, microsatellite instability, CpG island methylator phenotype, BRAF mutation, prognostic factors, gut microbiota, antitumor immunity
- MeSH terms
- Aged, Carcinoma, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mutation, Neoplasm Staging, Phenotype, Prognosis, Prospective Studies, Research Design, Biomarkers, Tumor, Colorectal Neoplasms, Databases, Factual, Proto-Oncogene Proteins p21(ras), Fusobacterium nucleatum, Phosphatidylinositol 3-Kinases, Proto-Oncogene Proteins B-raf, Kaplan-Meier Estimate, Microsatellite Instability, Class I Phosphatidylinositol 3-Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review